About Enhancer

Enhancer ID: E_01_0876
Species: human
Position : chr2:25730681-25732681
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: Colorectal cancer
Pubmed ID:  33116876
Enhancer experiment: Quantitative real-time polymerase chain reaction (QRT PCR), Western blot analysis and immunohistochemistry (IHC)
Enhancer experiment description: These results showed that ASXL2 could induce cell proliferation, which was associated with poor prognosis of CRC patients, suggesting that ASXL2 might be a new therapeutic target for CRC.

About Target gene

Target gene : --
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: These results showed that ASXL2 could induce cell proliferation, which was associated with poor prognosis of CRC patients, suggesting that ASXL2 might be a new therapeutic target for CRC.

About TF

TF name : ASXL2
TF experiment: ???????????qRT-PCR???????????????IHC?
TF experiment description: These results showed that ASXL2 could induce cell proliferation, which was associated with poor prognosis of CRC patients, suggesting that ASXL2 might be a new therapeutic target for CRC.

About Function

Enhancer function : These results showed that ASXL2 could induce cell proliferation, which was associated with poor prognosis of CRC patients, suggesting that ASXL2 might be a new therapeutic target for CRC.
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
These results showed that ASXL2 could induce cell proliferation, which was associated with poor prognosis of CRC patients, suggesting that ASXL2 might be a new therapeutic target for CRC.

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs